Vision Baby: Testing Lifelight for Neonatal Vital Signs in the NICU

Is this trial a fit for you?

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This observational study will enroll up to 256 critically ill or at-risk newborns in the NICU. Each infant will have heart rate, respiratory rate, SpO2, blood pressure, ECG, and temperature measured with standard equipment while also recording brief facial and upper-torso video clips at four intervals per hour. The videos, captured via a tablet app, will be uploaded to the cloud for separate analysis and will not provide measurements to clinicians or families. Sub-protocols will gather parent or guardian input through post-measurement questionnaires. Recording may last up to 120 seconds per event and up to three attempts may be made.

Why it matters

Who can join: the full rules

Inclusion Criteria:

* Infants admitted to the NICU (who may subsequently be moved onto a different inpatient ward)

Exclusion Criteria:

* Infants who are on a palliative care pathway

Where it's running

• Royal London Hospital
  London, London, United Kingdom Recruiting

Study contacts

• Principal investigator: Burak Salgin, BA MD BChir PhD — Barts & The London NHS Trust
• Study coordinator: Laurence Pearce, MBA
• Email: laurence@xim.ai
• Phone: +447803950356

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

• Continuous wearable vital-sign monitoring versus routine spot-checks after non-cardiac surgery

  This trial will test whether continuous wearable vital-sign monitoring can reduce the time abnormal signs go unnoticed in adults recovering on regular wards after major non-cardiac surgery.

  Recruiting Universitätsklinikum Hamburg-Eppendorf · Hamburg, Free and Hanseatic City of Hamburg · NCT07385092

• Adding azithromycin to ampicillin for late PPROM

  This test sees if adding a single dose of azithromycin to the usual ampicillin/amoxicillin treatment helps newborns when membranes break early between 34.0 and 36.6 weeks.

  Recruiting Phase 4 Sheba Medical Center · Ramat Gan, Israel · NCT07183462

• Long-term outcomes after FETO for severe left or right congenital diaphragmatic hernia

  This trial will test whether performing FETO in fetuses with isolated severe left or right CDH helps more babies survive to hospital discharge and have fewer long-term problems than standard care.

  Recruiting Johns Hopkins University · Baltimore, Maryland · NCT07166172

• Using a wireless ANNE One vital-sign device array to reduce bedside vital-sign measurement time

  This trial will see if using a wireless Bluetooth ANNE One vital-sign device array reduces the time staff spend obtaining and charting vital signs for adult inpatients on a general medical floor.

  Recruiting Northwestern University · Chicago, Illinois and 1 other locations · NCT06995742

• Comparing two bathing methods for children in the Pediatric Intensive Care Unit

  This study is testing whether traditional bathing or wipe bathing is better for the comfort and vital signs of children in the Pediatric Intensive Care Unit.

  Recruiting Izmir Katip Celebi University · Cordaleo, İzmir · NCT06836947

• Zeleciment Rostudirsen (DYNE-251) for Duchenne Muscular Dystrophy in Ambulatory Boys

  This trial tests whether intravenous Zeleciment Rostudirsen (DYNE-251) given every 4 weeks is safe and helps improve function in ambulatory boys with Duchenne muscular dystrophy who have a specific dystrophin gene mutation.

  Recruiting Phase 3 Dyne Therapeutics · Hillsborough, North Carolina · NCT07608432

How to take part

1. Review the eligibility criteria above with your treating physician.
2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.